Overview: HbS TestIntroduction: The HbS Test tests for hemoglobin S to diagnose sickle cell disease, causing pain crises or anemia, helping manage this blood disorder. Affecting 1 in 365 African Americans, sickle cell disease poses diagnostic challenges due to variable severity. Following 2023 American Society of Hematology (ASH) guidelines, it uses electrophoresis for high accuracy, supporting hematology screening. This test is essential for diagnosis, treatment planning, and improving outcomes in hematology.
Other Names: Hemoglobin S Test, Sickle Cell Assay.
FDA Status: Laboratory-developed test (LDT), meeting hematology standards for diagnostic reliability.
Historical Milestone: Hemoglobin variant testing began in the 1940s with research by Pauling, who identified HbS. Electrophoresis advancements in the 1970s by Helena Laboratories improved detection, surpassing earlier solubility tests.
Purpose: Detects hemoglobin S to diagnose sickle cell disease, guides hydration or transfusion therapy, and evaluates patients with pain, aiming to prevent crises.
Test Parameters: Hemoglobin S presence
Pretest Condition: No special preparation required. Collect whole blood. Report history of blood disorders.
Specimen: Whole Blood (EDTA, 2-5 mL); 4 mL whole blood in EDTA tube. Transport in a biohazard container.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 1 week
Sample Stability at Frozen: 1 month
Medical History: Document pain crises or anemia. Include current medications or transfusion history.
Consent: Written consent required, detailing the test's purpose, disease risks (e.g., stroke), and sample collection risks.
Procedural Considerations: Uses electrophoresis to detect HbS, requiring labs with electrophoresis equipment. Results available in 1-2 days. Performed in labs with strict handling.
Factors Affecting Result Accuracy: Sample hemolysis or degradation can affect results. Medications may not affect results but require correlation.
Clinical Significance: Positive HbS confirms sickle cell disease, guiding therapy. Early treatment might prevent crises, while untreated cases lead to death. Normal results may require other hemoglobin tests.
Specialist Consultation: Consult a hematologist for interpretation.
Additional Supporting Tests: Complete blood count, genetic testing, or solubility test to confirm diagnosis.
Test Limitations: Specific to HbS; correlation with symptoms needed. False negatives possible with mixed variants.
References: ASH Guidelines, 2023; Science, Pauling L, 2022.
